TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06302439

PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study was terminated by the sponsor prior to planned completion based on a review of the data across indications and overall program considerations. Study termination was not related to participant safety.”

The sponsor’s own words in the registry.

Life of this trial

2024202520262027Registered2024-02-16Started2024-07-25Stopped2026-08-28

Vital statistics

Status
Terminated
Sponsor
Inozyme Pharma
Sponsor type
Industry
Conditions
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency; ATP-Binding Cassette Subfamily C Member 6 Deficiency
Interventions
No Intervention for this observational study
Participants
54
Sites
14
Countries
Canada, Germany, Italy, Japan, Oman, Spain, Turkey (Türkiye), United Kingdom, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.